Sun Pharmaceutical Industries Ltd share price logo

Sun Pharmaceutical Industries Ltd

NSE: SUNPHARMA

BSE: 524715

Large Cap

Healthcare Sector

Pharma Sector

₹1778.70

+31.40

(+1.80%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

🔔 Block Trade Alert

Sun Pharmaceutical Industries recorded an NSE block trade of approximately 445,511 shares valued at Rs. 78.31 crore at Rs. 1757.80 per share.

Sun Pharmaceutical Stock Performance

as on April 29, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹1,750.00
    ₹1,789.80
    downward going graph

    1.61%

    Downside

    0.62%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹1,548.00
    ₹1,851.20
    downward going graph

    12.97%

    Downside

    4.08%

    Upside

    downward going graph

Sun Pharmaceutical share price movements today

Previous Close
₹1,747.30
Open
₹1,756.00
Volume
98.09L
Upper Circuit
₹1,922.00
Lower Circuit
₹1,572.60
Day's Low - High
₹1,750.00 - ₹1,789.80
52 Week Low - High
₹1,548.00 - ₹1,851.20

Sun Pharmaceutical Historical Returns

1 Month Return
-0.56 %
3 Month Return
+ 9.94 %
1 Year Return
-3.22 %
3 Year Return
+ 79.57 %
5 Year Return
+ 171.11 %

Sun Pharmaceutical Fundamentals

as on April 29, 2026 at 4:01 pm IST

Market Cap

₹4,19,235.80 Cr

Return on Equity (ROE)

17.83

PE Ratio (TTM)

38.4

Return on capital employed (ROCE)

16.29

Industry PE ratio

43.2

Beta (LTM)

0.43

P/B Ratio

17.11

Dividend Yield

0.92

PEG Ratio

-17.46

Quarterly Earnings Growth YOY

16.57

EPS (TTM)

45.76

Sector

Pharmaceuticals

Book Value

301

Sun Pharmaceutical Stock Valuation

as on April 29, 2026 at 4:01 pm IST

Sun Pharmaceutical in the last 5 years

  • Overview

  • Trends

Lowest (19.47x)

March 23, 2020

Today (38.40x)

April 28, 2026

Industry (43.20x)

April 28, 2026

Highest (184.63x)

August 28, 2020

LowHigh

Today’s Price to Earnings Ratio: 38.40x

Sun Pharmaceutical Technical Analysis

Track how Sun Pharmaceutical technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Bullish

Overall

Bearish8
Bullish4
Neutral3

Oscillators

Name

Value

Action

MACD level (12,26)
-0.86
Bearish
CCI (20)
-319.82
Bullish
RSI (14)
42.72
Neutral
Momentum (10)
-2.8
Bullish
ADI (14)
19.02
Neutral
Ultimate Oscillator (7,14,28)
59.04
Neutral

Moving Averages

Name

Value

Action

SMA (20)
1779.41
Bearish
EMA (20)
1778.85
Bearish
VWMA (20)
1778.65
Bearish
SMA (50)
1781.13
Bearish
EMA (50)
1778.27
Bearish
SMA (200)
1765.7
Bullish
EMA (200)
1768.67
Bullish
KAMA (200)
1780.57
Bearish
DEMA (200)
1777.49
Bearish

Sun Pharmaceutical Industries Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Sun Pharmaceutical with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Sun Pharmaceutical Industries Ltd image
Sun Pharmaceutical Industries Ltd
BUY4,19,235.8034.22%0.5210,98052,578
Divis Laboratories Ltd image
Divis Laboratories Ltd
BUY1,70,762.6612.9%0.502,1919,360
Torrent Pharmaceuticals Ltd image
Torrent Pharmaceuticals Ltd
BUY1,41,568.3446.91%0.661,91111,516
Biocon Ltd image
Biocon Ltd
BUY58,806.53-1.58%0.781,42915,261
Gland Pharma Ltd image
Gland Pharma Ltd
BUY29,010.31-6.72%0.536985,616
See all

Market expectation of Sun Pharmaceutical Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

90.32%

Buy

0.00%

Hold

9.68%

Sell

Sun Pharmaceutical Stock’s Investor Sentiment and Interest

Investment in Sun Pharmaceutical Industries Ltd Shares on INDmoney has grown by 214.36% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:214.36% versus previous 30 day period

Search interest for Sun Pharmaceutical Industries Ltd Stock has increased by 80% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:80% versus previous 30 day period

Sun Pharmaceutical Industries Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
11,785.15
12,003.11
12,156.86
11,813.33
12,524.51
13,264.22
13,436.94
12,815.58
13,786.07
14,405.22
15,469.07
Other Income
204.44
293.61
250.2
605.94
532.55
354
465.62
612.87
464.46
469.92
578.84
Total Income
12,145.28
12,486.02
12,630.9
12,588.84
13,185.3
13,645.39
14,141.08
13,571.71
14,315.86
14,948.23
16,099.38
Expenses
8,931.94
9,013.03
8,973.68
9,049.39
9,045.13
9,352.43
9,982.61
9,604.43
10,367.74
9,951.26
11,061.53
Operating Profit
2,853.21
2,990.08
3,183.18
2,763.94
3,479.38
3,911.79
3,454.33
3,211.15
3,418.33
4,453.96
4,407.54
Operating Profit Margin %
24.21%
24.91%
26.18%
23.4%
27.78%
29.49%
25.71%
25.06%
24.8%
30.92%
28.49%
Profit Before Interest, Tax and Depreciation
3,213.34
3,472.99
3,657.22
3,539.45
4,140.17
4,292.96
4,158.47
3,967.28
3,948.12
4,996.97
5,037.85
Interest
80.88
49.29
34.73
73.57
61.54
69.17
51.51
49.14
74.8
99.86
78.36
Depreciation
651.32
632.82
622.14
650.36
655.13
625.91
630.56
663.79
700.55
729.5
732.33
Profit Before Tax
2,481.14
2,790.88
3,000.35
2,815.52
3,423.5
3,597.88
3,476.4
3,254.35
3,172.77
4,167.61
4,227.16
Tax Paid
468.1
390.1
432.32
148.93
552.25
567.21
558.86
1,093.71
870.15
1,030.52
826.07
Profit After Tax
2,013.04
2,400.78
2,568.03
2,666.59
2,871.25
3,030.67
2,917.54
2,160.64
2,302.62
3,137.09
3,401.09
Total Net profit including share of profit / Loss from associate company
2,005.65
2,385.1
2,560.54
2,658.74
2,860.51
3,037.33
2,912.98
2,153.93
2,292.87
3,124.95
3,381.17
EPS
8.4
9.9
10.5
11.1
11.8
12.7
12.1
9
9.5
13
14
Actual EPS
8.4
9.9
10.5
11.1
11.8
12.7
12.1
9
9.5
13
14
Adjusted EPS
8.4
9.9
10.5
11.1
11.8
12.7
12.1
9
9.5
13
14
Diluted EPS
8.4
9.9
10.5
11.1
11.8
12.7
12.1
9
9.5
13
14

Sun Pharmaceutical Industries Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
26,065.94
28,686.28
32,325.17
33,233.08
38,426.42
43,278.87
47,758.45
52,041.25
Other Income
838.76
1,025.49
635.98
835.52
921.51
634.52
1,354.19
1,965.04
Total Income
27,328.22
30,091.4
33,473.48
34,333.66
39,576
44,520.2
49,851.04
54,543.48
Expenses
21,831.83
23,972.7
26,108.38
29,312.91
32,823.59
32,410.34
35,968.04
37,984.6
Operating Profit
4,234.11
4,713.58
6,216.79
3,920.17
5,602.83
10,868.53
11,790.41
14,056.65
Operating Profit Margin %
16.24%
16.43%
19.23%
11.8%
14.58%
25.11%
24.69%
27.01%
Profit Before Interest, Tax and Depreciation
5,496.39
6,118.7
7,365.1
5,020.75
6,752.41
12,109.86
13,883
16,558.88
Interest
517.57
555.25
302.73
141.43
127.35
172
238.47
231.36
Depreciation
1,499.84
1,753.25
2,052.78
2,079.95
2,143.74
2,529.43
2,556.64
2,575.39
Profit Before Tax
3,478.98
3,810.2
5,009.59
2,799.37
4,481.32
9,408.43
11,087.89
13,752.13
Tax Paid
911.04
600.88
822.8
514.69
1,075.5
847.59
1,439.45
2,772.03
Profit After Tax
2,567.94
3,209.32
4,186.79
2,284.68
3,405.82
8,560.84
9,648.44
10,980.1
Total Net profit including share of profit / Loss from associate company
2,542.5
3,207.86
4,171.96
2,272.35
3,389.28
8,512.94
9,610.03
10,964.75
EPS
8.73
11.11
15.69
12.1
13.6
35.3
39.9
45.6
Actual EPS
8.73
11.11
15.69
12.1
13.6
35.3
39.9
45.6
Adjusted EPS
8.73
11.11
15.69
12.1
13.6
35.3
39.9
45.6
Diluted EPS
8.73
11.11
15.69
12.1
13.6
35.3
39.9
45.6

Sun Pharmaceutical Industries Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
6,685.86
7,082.21
3,907.15
2,196.45
6,554.77
6,170.37
8,984.54
4,959.33
12,134.98
14,072.09
Cash Flow from Investing Activities
-3,949.13
-4,186.15
-3,103.8
-310.08
-2,225.32
406.53
-5,555.86
-7,219.92
-762.9
-5,183.15
Cash Flow from Financing Activities
-1,888.53
-2,285.39
-1,539.26
-2,730.52
-5,715.14
-5,980.48
-5,193.46
2,376.07
-6,710.16
-7,905.82
Net Cash Flow
848.2
610.67
-735.91
-844.15
-1,385.69
596.42
-1,764.78
115.48
4,661.92
983.12

Sun Pharmaceutical Stock Shareholding Pattern

Numbers in percentages

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Promoters
54.48%
54.48%
54.48%
54.48%
54.48%
54.48%
54.48%
54.48%
54.48%
54.48%
54.48%
54.48%
DII
19.75%
19.67%
17.97%
18.83%
19.28%
18.61%
18.55%
18.7%
19.5%
20.23%
20.82%
21.11%
FII
0%
16.79%
0%
17.72%
17.23%
18.02%
18.05%
17.96%
17.26%
16.55%
16.12%
15.93%
Public
9.29%
9.06%
8.92%
8.97%
9.01%
8.89%
8.92%
8.87%
8.77%
8.73%
8.58%
8.48%
Total Outstanding Shares
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
Total Shareholders
6,24,561
6,16,588
6,12,626
6,31,392
6,73,217
6,57,317
6,89,623
7,04,983
7,23,770
7,43,877
7,10,900
6,90,957

Mutual Funds that own Sun Pharmaceutical Stock

Check out the Mutual Funds with significant holdings in Sun Pharmaceutical.

Sun Pharmaceutical Corporate Actions

View detailed summary of the earnings and dividend history of Sun Pharmaceutical.

  • Sun Pharmaceutical Industries Ltd Earnings Results

    Sun Pharmaceutical Industries Ltd’s net profit jumped 16.03% since last year same period to ₹3,368.81Cr in the Q3 2025-2026. On a quarterly growth basis, Sun Pharmaceutical Industries Ltd has generated 8.05% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Sun Pharmaceutical Industries Ltd Dividends January,2026

    In the quarter ending December 2025, Sun Pharmaceutical Industries Ltd has declared dividend of ₹11.00 per share on 31 Jan 2026 - translating a dividend yield of 1.55%.

    Read More about Dividends

Indices Featuring Sun Pharmaceutical Stock

Check stock indices that include Sun Pharmaceutical.

BSE MFG

₹1,111.89

1.40 (▲15.33%)

S&P BSE Dividend Stability

₹1,056.86

0.57 (▲5.94%)

S&P BSE 100 LargeCap TMC

₹9,067.03

0.57 (▲51.54%)

NIFTY 50

₹24,177.65

0.76 (▲181.95%)

S&P BSE Low Volatility

₹1,779.72

0.57 (▲10.01%)

Nifty 500

₹22,871.00

0.46 (▲105.40%)

S&P BSE 100 ESG

₹407.52

0.56 (▲2.27%)

SENSEX

₹77,496.36

0.79 (▲609.45%)

Nifty100 Eq Weig

₹33,917.05

0.21 (▲70.85%)

Nifty Healthcare

₹14,941.05

0.25 (▲36.60%)

Nifty LargeMidcap 250

₹16,328.40

0.28 (▲44.95%)

NIFTY 100

₹25,106.10

0.61 (▲151.10%)

Nifty100 Low Volatility 30

₹19,742.55

0.53 (▲104.50%)

S&P BSE SENSEX 50

₹25,291.67

0.73 (▲183.52%)

Nifty 200

₹13,825.10

0.47 (▲65.25%)

BSE 100

₹25,598.01

0.60 (▲151.79%)

NIFTY PHARMA

₹23,260.85

0.44 (▲102.70%)

BSE 200

₹11,200.85

0.44 (▲49.22%)

BSE Healthcare

₹44,637.26

0.17 (▲74.00%)

S&P BSE 250 LargeMidCap

₹10,646.74

0.44 (▲46.95%)

BSE 500

₹35,811.60

0.45 (▲161.33%)

Insights on Sun Pharmaceutical Industries Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 13.57K Cr → 16.09K Cr (in ₹), with an average increase of 5.5% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, 2.14K Cr → 3.36K Cr (in ₹), with an average increase of 13.3% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 152.6% return, outperforming this stock by 73.0%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 54.48% of holdings in Mar 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 25.9% return, outperforming this stock by 29.1%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 16.12% to 15.93% in Mar 2026 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 8.58% to 8.48% in Mar 2026 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, SUNPHARMA stock has moved down by -0.6%

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 12.09% to 11.96% in Mar 2026 quarter

Sun Pharmaceutical Stock Futures & Options Contracts

View the latest movement in Sun Pharmaceutical Futures & Options, including strike prices, expiry dates, and percentage changes.

Sun Pharmaceutical Options

Name
Expiry
Strike Price
LTP
Absolute Change
Change
SUNPHARMA 26 May ₹1800 Call
May 26, 2026
₹1800
₹33.05
-3
-8.32%
SUNPHARMA 26 May ₹1780 Call
May 26, 2026
₹1780
₹42.65
-0.8
-1.84%
SUNPHARMA 26 May ₹1760 Call
May 26, 2026
₹1760
₹53.5
0.65
1.23%
SUNPHARMA 26 May ₹1900 Call
May 26, 2026
₹1900
₹9.75
-3.6
-26.97%

Sun Pharmaceutical Futures

Name
Expiry
Strike Price
LTP
Absolute Change
Change
SUNPHARMA 26 May Fut
May 26, 2026
-
₹1781.5
22.51
1.28%
SUNPHARMA 30 Jun Fut
June 30, 2026
-
₹1793.6
24.24
1.37%
SUNPHARMA 28 Jul Fut
July 28, 2026
-
₹1802
29.25
1.65%

About Sun Pharmaceutical Industries Ltd

Sun Pharmaceutical Industries Ltd., incorporated in 1983, is a global specialty generic pharmaceuticals company with a presence in over 150 countries. The company is headquartered in Mumbai, India, and has operations in three primary lines of business: branded formulations, specialty generics, and active pharmaceutical ingredients (API).

Sun Pharma's branded formulations include products for cardiovascular, central nervous system, gastroenterology, ophthalmology, and dermatology. Sun Pharma's specialty generics include injectables, inhalants, and complex products. Sun Pharma's API portfolio includes products for a range of therapeutic areas, including cardiovascular, central nervous system, gastroenterology, and dermatology.

Sun Pharma's top products include Modalert, a generic version of Modafinil for treating sleep disorders; Glocip, a generic version of Glipizide for treating diabetes; and Doxicip, a generic version of Doxycycline for treating bacterial infections. Sun Pharma's popular brands include Revital, a multivitamin supplement; Tazret, a topical retinoid for treating psoriasis; and Olmecip, a generic version of Olmesartan for treating hypertension.

Revenue: ₹15,469.07Cr as on December 2025 (Q3 FY26)
Net Profit: ₹3,401.09Cr as on December 2025 (Q3 FY26)
Listing date: 08 Feb, 1995
Revital Share Price
Volini Share Price
Abzorb Share Price
Pepfiz Share Price
OrganisationSun Pharmaceutical Industries Ltd
HeadquartersMumbai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs

What is Sun Pharmaceutical share price today?

Sun Pharmaceutical share price today stands at ₹1778.7 as on at the close of the market. Sun Pharmaceutical share today touched a day high of ₹1789.8 and a low of ₹1750.

What is the 52 week high and 52 week low range for Sun Pharmaceutical share?

Sun Pharmaceutical touched a 52 week high of ₹1851.2 and a 52 week low of ₹1548. Sun Pharmaceutical share price today i.e. is closed at ₹1778.7, which is -3.92% down from its 52 week high and 14.90% up from its 52 week low.

What is Sun Pharmaceutical's market capitalisation today?

Sun Pharmaceutical market capitalisation is ₹4,19,235.80 Cr as on .

How to buy Sun Pharmaceutical shares?

To buy Sun Pharmaceutical shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for SUNPHARMA or Sun Pharmaceutical Industries Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Sun Pharmaceutical shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Sun Pharmaceutical trading volume today?

Sun Pharmaceutical trading volume is 98.09L as on . This means that 98.09L shares of Sun Pharmaceutical were bought and sold on the stock market during today's trading session.